Pioglitazone abrogates cyclosporine-evoked hypertension via rectifying abnormalities in vascular endothelial function

Biochemical Pharmacology

Volumn 81, Issue 4, 2011, Pages 526-533

  El Mas, Mahmoud M ^a   El Gowelli, Hanan M ^a   Abd Elrahman, Khaled S ^a   Saad, Evan I ^a   Abdel Galil, Abdel Galil A ^a   Abdel Rahman, Abdel A ^b  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Blood pressure; Cyclosporine; Endothelium dependent relaxations; Oxidative stress; Pioglitazone

Indexed keywords

ADIPONECTIN; CAPTOPRIL; CARBACHOL; CYCLOSPORIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; OLIVE OIL; PIOGLITAZONE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HISTOLOGY; HYPERTENSION; HYPOTHESIS; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; ANTIOXIDANTS; AORTA; CYCLOSPORINE; ENDOTHELIUM, VASCULAR; HYPERTENSION; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; LIPIDS; NITRIC OXIDE SYNTHASE TYPE III; RATS; THIAZOLIDINEDIONES;

EID: 78751579181     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.11.013     Document Type: Article

References (44)

1. C. Ponticelli, G. Montagnino, A. Aroldi, C. Angelini, M. Braga, and A. Tarantino Hypertension after renal transplantation Am J Kidney Dis 21 1993 73 78
2. M.A. Diaz, C. Cisneros, J.C. Montejo, C. Garcia, J.A. Cantalapiedra, and F. Perez Systemic arterial hypertension in the immediate postoperative period of liver transplantation Transplant Proc 21 1989 3547 3548
3. A. Eid, J.D. Perkins, J. Rakela, and R.A. Krom Conversion from standard cyclosporine to low-dose cyclosporine in liver transplant recipients: effect on nephrotoxicity and hypertension beyond one year Transplant Proc 21 1989 2238 2239
4. 1 receptor mediates the hypertensive effect of cyclosporine in rats Brain Res 1248 2009 96 106
5. A. Nishiyama, H. Kobori, T. Fukui, G.X. Zhang, L. Yao, and M. Rahman Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension Hypertension 42 2003 754 760
6. S.M. Gardiner, J.E. March, P.A. Kemp, B. Fallgren, and T. Bennett Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats Br J Pharmacol 141 2004 634 643
7. M.M. El-Mas, M.M. Mohy El-Din, S.M. El-gowilly, and F.M. Sharabi Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and β-adrenergic renal vasodilations Eur J Pharmacol 487 2004 149 158
8. M.M. El-Mas, E.A. Afify, A.G. Omar, and F.M. Sharabi Cyclosporine adversely affects baroreflexes via inhibition of testosterone modulation of cardiac vagal control J Pharmacol Exp Ther 301 2002 346 354
9. M.M. El-Mas, E.A. Afify, A.G. Omar, M.M. Mohy El-Din, and F.M. Sharabi Testosterone depletion contributes to cyclosporine-induced chronic impairment of acetylcholine renovascular relaxations Eur J Pharmacol 468 2003 217 224
10. J. Navarro-Antolín, M. Redondo-Horcajo, C. Zaragoza, A. Alvarez-Barrientos, A.P. Fernández, and E. León-Gómez Role of peroxynitrite in endothelial damage mediated by Cyclosporine A Free Radic Biol Med 42 2007 394 403
11. J. Galle, C. Lehmann-Bodem, U. Hubner, A. Heinloth, and C. Wanner CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O(2)(-) formation Nephrol Dial Transplant 15 2000 339 346
12. L. Michalik, J. Auwerx, J.P. Berger, V.K. Chatterjee, C.K. Glass, and F.J. Gonzalez International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors Pharmacol Rev 58 2006 726 741
13. J.B. Majithiya, A.N. Paramar, and R. Balaraman Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats Cardiovasc Res 66 2005 150 161
14. T.J. Heppner, A.D. Bonev, D.M. Eckman, M.F. Gomez, G.V. Petkov, and M.T. Nelson Novel PPARgamma agonists GI 262570, GW 7845, GW 1929, and pioglitazone decrease calcium channel function and myogenic tone in rat mesenteric arteries Pharmacology 73 2005 15 22
15. R.K. Dubey, H.Y. Zhang, S.R. Reddy, M.A. Boegehold, and T.A. Kotchen Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats Am J Physiol 265 1993 R726 R732
16. N. Maeda, M. Takahashi, T. Funahashi, S. Kihara, H. Nishizawa, and K. Kishida PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein Diabetes 50 2001 2094 2099
17. Y. Iwashima, T. Katsuya, K. Ishikawa, N. Ouchi, M. Ohishi, and K. Sugimoto Hypoadiponectinemia is an independent risk factor for hypertension Hypertension 43 2004 1318 1323
18. A. Barac, U. Campia, L.A. Matuskey, L. Lu, and J.A. Panza Effects of peroxisome proliferator-activated receptor-gamma activation with pioglitazone on plasma adipokines in nondiabetic patients with either hypercholesterolemia or hypertension Am J Cardiol 101 2008 980 985
19. T. Matsunami, Y. Sato, S. Ariga, T. Sato, H. Kashimura, and Y. Hasegawa Regulation of oxidative stress and inflammation by hepatic adiponectin receptor 2 in an animal model of nonalcoholic steatohepatitis Int J Clin Exp Pathol 3 2010 472 474
20. 1-adrenoceptor reactivity in rat aortic smooth muscle Eur J Pharmacol 322 1997 201 210
21. M.M. El-Mas, F.M. Sharabi, S.M. El-gowilly, and M.M. Mohy El-Din Inhibition of nitric oxide-guanylate cyclase-dependent and -independent signaling contributes to impairment of β-adrenergic vasorelaxations by cyclosporine Biochem Pharmacol 73 2007 359 367
22. M.M. El-Mas, J. Zhang, and A.A. Abdel-Rahman Upregulation of vascular inducible nitric oxide synthase mediates the hypotensive effect of ethanol in conscious female rats J Appl Physiol 100 2006 1011 1018
23. M.M. El-Mas, M. Fan, and A.A. Abdel-Rahman Endotoxemia-mediated induction of cardiac inducible nitric-oxide synthase expression accounts for the hypotensive effect of ethanol in female rats J Pharmacol Exp Ther 324 2008 368 375
24. J.F. Gerkens Cyclosporine treatment of normal rats produces a rise in blood pressure and decreased renal vascular responses to nerve stimulation, vasoconstrictors and endothelium-dependent dilators J Pharmacol Exp Ther 250 1989 1105 1112
25. M. Fahim, M.M. El-Mas, A.A. Abdel-Rahman, and S.J. Mustafa Influence of aortic baroreceptor denervation on adenosine receptor-mediated relaxation of isolated rat aorta Eur J Pharmacol 254 1994 183 191
26. H. Ohkawa, N. Ohishi, and K. Yagi Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 95 1979 351 358
27. S. Marklund, and G. Marklund Involvement of superoxide anion radical in autooxidation of pyrogallol and a convenient assay for SOD Eur J Biochem 47 1974 469 474
28. 2 and nitric oxide in CsA-induced hypertension Prostaglandins Leukot Essent Fatty Acids 68 2003 233 238
29. M. Olukman, C.E. Orhan, F.G. Celenk, and S. Ulker Apocynin restores endothelial dysfunction in streptozotocin diabetic rats through regulation of nitric oxide synthase and NADPH oxidase expressions J Diabetes Complications 24 2010 415 423
30. S. Bertuglia, and A. Giusti Microvascular oxygenation and oxidative stress during postischemic reperfusion, PO2, ROS, and NO during reperfusion Adv Exp Med Biol 566 2005 23 29
31. T. Jung, M. Engels, B. Kaiser, D. Poppek, and T. Grune Intracellular distribution of oxidized proteins and proteasome in HT22 cells during oxidative stress Free Radic Biol Med 40 2006 1303 1313
32. S. Ülker, P.P. Mckeown, and U. Bayraktutan Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities J Hypertens 41 2003 534 539
33. R. Saiki, M. Okazaki, S. Iwai, T. Kumai, S. Kobayashi, and K. Oguchi Effects of pioglitazone on increases in visceral fat accumulation and oxidative stress in spontaneously hypertensive hyperlipidemic rats fed a high-fat diet and sucrose solution J Pharmacol Sci 105 2007 157 167
34. M. Zhang, S.H. Zhou, S. Zhao, X.P. Li, L.P. Liu, and X.Q. Shen Pioglitazone can downregulate bone morphogenetic protein-2 expression induced by high glucose in human umbilical vein endothelial cells Pharmacology 81 2008 312 316
35. T. Quaschning, T. Mainka, M. Nauck, L.C. Rump, C. Wanner, and A. Kramer-Guth Immunosuppression enhances atherogenicity of lipid profile after transplantation Kidney Int Suppl 71 1999 S235 S237
36. H. Superko, W. Haskell, and C. DiRiccio Lipoprotein and hepatic lipase activity and high-density lipoprotein sub-classes after cardiac transplantation Am J Cardiol 66 1990 1131 1134
37. P.C. de Groen Cyclosporine, low density lipoprotein, and cholesterol Mayo Clin Proc 63 1988 1012 1021
38. J. López-Miranda, E. Vilella, F. Perez-Jimenez, A. Espino, J.A. Jimenez-Pereperez, and L. Masana Low-density lipoprotein metabolism in rats treated with cyclosporine Metabolism 42 1993 678 683
39. K.J. Moore, E.D. Rosen, M.L. Fitzgerald, F. Randow, L.P. Andersson, and D. Altshuler The role of PPAR-gamma in macrophage differentiation and cholesterol uptake Nat Med 7 2001 41 47
40. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
41. D. Bruemmer, F. Blaschke, and R.E. Law New targets for PPARgamma in the vessel wall: implications for restenosis Int J Obes 29 2005 S26 S30
42. J.J. Curtis, D.A. Laskow, P.A. Jones, B.A. Julian, R.S. Gaston, and R.G. Luke Captopril-induced fall in glomerular filtration rate in cyclosporine-treated hypertensive patients J Am Soc Nephrol 3 1993 1570 1574
43. T. Rampino, A. Ranghino, C. Guidetti, M. Gregorini, G. Soccio, and M. Maras Activation of PPARgamma enhances in vitro the immunosuppressive effect of cyclosporine on T lymphocytes Transpl Immunol 18 2007 32 36
44. Y. Tanaka, T. Hasegawa, Z. Chen, Y. Okita, and K. Okada Renoprotective immunosuppression by pioglitazone with low-dose cyclosporine in rat heart transplantation J Thorac Cardiovasc Surg 138 2009 744 751